Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1994-04-15
1996-12-10
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
534 16, 556 50, 556 63, 556107, 556117, 556134, 556148, 562489, 1286534, 436173, A61K 4904, C07F 500, C07F 1300, C07F 1500
Patent
active
055828140
ABSTRACT:
Paramagnetic metal complexes of 1-(p-n-butylbenzyl)diethylenetriamine pentaacetic acid and pharmaceutically acceptable salts thereof are effective as tissue-specific MRI contrast agents, and in particular as hepatobiliary MRI contrast agents.
REFERENCES:
patent: 3632637 (1972-01-01), Martell
patent: 4150047 (1979-04-01), Coe et al.
patent: 4308249 (1981-12-01), Frank et al.
patent: 4331647 (1982-05-01), Goldenberg
patent: 4352751 (1982-10-01), Wieder et al.
patent: 4361544 (1982-11-01), Goldenberg
patent: 4401647 (1983-08-01), Krohn et al.
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4615879 (1986-10-01), Runge et al.
patent: 4639365 (1987-01-01), Sherry
patent: 4647447 (1987-03-01), Gries et al.
patent: 4687658 (1987-08-01), Quay
patent: 4714607 (1987-12-01), Klaveness
patent: 4746507 (1988-05-01), Quay
patent: 4834964 (1989-05-01), Rosen
patent: 4859451 (1989-08-01), Quay et al.
patent: 4880008 (1989-11-01), Lauffer
patent: 4885363 (1989-12-01), Tweedle et al.
patent: 4899755 (1990-02-01), Lauffer et al.
patent: 4957939 (1990-09-01), Gries et al.
patent: 4963344 (1990-10-01), Gries et al.
patent: 4980502 (1990-12-01), Felder et al.
patent: 5078986 (1992-01-01), Bosworth et al.
patent: 5250285 (1993-10-01), Lauffer et al.
patent: 5318771 (1994-06-01), Lauffer et al.
patent: 5362475 (1994-11-01), Gries et al.
Bagley et al., "Distribution of Intravenously Administered Ferrioxamine-59 and Ferric N,N'-Ethylenebis (.alpha. Imino-2-Hydroxy-5-Chlorophenylacetate) in Rats", Proc. Soc. Exptl. Biol. Med., 127, pp. 798-801 (1968).
Brasch et al., "Contrast-Enhanced NMR Imaging: Animal Studies Using Gadolinium-DTPA Complex", AJR, pp. 625-630 (1984).
Brittain et al., "Luminescence and NMR Studies of the Conformational Isomers of Lanthanide Complexes with an Optically Active Polyaza Polycarboxylic Macrocycle," Inorg. Chem., 23, pp. 4459-4466 (1984).
Chen et al., "Paramagnetic Metalloporphyrins as Potential Contrast Agents in NMR Imaging", FEBS Letters, 168, pp. 70-74 (1984).
Davison, "Protein Binding", Fundamentals of Drug Metabolism and Drug Disposition, La Du et al., eds., R. E. Krieger Pub. Co., Malabar, Fla., pp. 63-75 (1971).
Desreux et al., "Nuclear Magnatic Resonance Spectroscopy of Lanthanide Complexes with a Tetraacetic Tetraaza Macrocycle. Unusual Conformation Properties", Inorg. Chem., 19, pp. 1319-1324 (1980).
Felix et al., "Brain Tumors MR Imaging with Gadolinium-DTPA", Radiology, 156, pp. 681-688 (1985).
Graf et al., "Iron-catalyzed Hydroxyl Radical Formation", J. Biol. Chem., 259, pp. 3620-3624 (1984).
Haddock et al., "Biliary Excretion of Chelated Iron", Proc. Soc. Exptl. Biol. Med., 120, pp. 663-668 (1965).
Konishiroku Photo Industry Co., Ltd., "Processing of Silver Halide Color Photographic Material", Chemical Abstracts, 101, p. 537, Abstract No. 219677p (1984).
Krishnamurthy et al., "Technetium-99m-Iminodiacetic Acid Organic Anions: Review of Biokinetics and Clinical Application in Hepatology", Hepatology, 9, pp. 139-153 (1989).
Lauffer et al., "Stereospecific Binding of rac-Iron(III) N,N'-Ethylenebis[(5-bromo-2-hydroxyphenyl)glycinate) ]to the Bilrubin Site on Human Serum Ablumin, " J.A.C.S., 109, pp. 2216-2218 (1987).
Lauffer et al., "Albumin Binding of Paramagnetic Hepatobiliary Contrast Agents: Enhancement of Outer Sphere Relaxivity", Nucl. Med. Biol., 15, pp. 45-46 (1988).
Lauffer et al., "Iron-EHPG as an Hepatobiliary MR Contrast Agent: Initial Imaging and Biodistribution Studies", J. Comp. Assist. Tomog., 9, pp. 431-438 (1985).
Lauffer et al., "Hepatobiliary MR Contrast Agents: 5-Substituted Iron-EHPG Derivatives", Magn. Res. Med., 4, pp. 582-590 (1987).
Lauffer et al., "Preparation and Water Relaxation Properties of Proteins Labeled with Paramagnetic Metal Chelates", Magn. Res. Imaging, 3, pp. 11-16 (1985).
Lauffer, "Paramagnetic Metal Complexes as Water Proton Relaxation Agents for NMR Imaging: Theory and Design," Chem. Rev., 87, pp. 901-927 (1987).
Levi et al., "Two Hepatic Cytoplasmic Protein Fractions, Y and Z, and Their Possible Role in the Hepatic Uptake of Bilirubin, Sulfobromophthalein, and Other Anions", J. Clin. Invest., 48, pp. 2156-2167 (1969).
Martell et al., "Development of Iron Chelators for Cooley's Anemia," Inorganica Chimica Acta, 138, pp. 215-230 (1987).
Martell, "The Design and Synthesis of Chelating Agents", Development of Iron Chelators for Clinical Use, Martell et al., eds., Elsevier North Holland, Inc., pp. 65-104 (1981).
McCandlish et al., "Comparison of the Structures and Aqueous Solutions of [o-Phenylenediaminetetraacetato (4-)] cobalt (II) and [Ethylenediaminetetraacetato (4-1)] cobalt (II) Ions", Inorg. Chem., 17, pp. 1383-1394 (1978).
Moerlein et al., "The Chemistry of Gallium and Indium as Related to Radiopharmaceutical Production", In. J. Nucl. Med. Biol., 8, pp. 277-287 (1981).
Moore et al., "Synthesis, Characterization, and Solid-State Structure of a New Hexachelating Ligand and Its Complex with Gallium(III)," Inorg. Chem., 28, pp. 1504-1506 (1989).
Motekaitis et al., "New Synthetic,Selective, High-Affinity Ligands for Effective Trivalent Metal Ion Binding and Transport", Inorganica Chimica Acta, 198-200, pp. 421-428 (1992).
Pecoraro et al., "Gallium and Indium Imaging Agents. 2. Complexes of Sulfonated Catechoylamide Sequestering Agents", Inorg. Chem., 21, pp. 2209-2115 (1982).
"Phenolic derivatices of (hydroxyalkyl)alky=-lenediamineacetic acids and their salts", Chemical Abstracts, 89, p. 561, Abstract No. 215057x (1978).
Rocklage et al., "Manganese(II) N,N'-Dipyridoxyl-ethylenediamine-N,N'-diacetate 5,5'-Bis(phosphate). Synthesis and Characterization of a Paramagnetic Chelate for Magnetic Resonance Imaging Enhancement", Inorg. Chem., 28, pp. 477-485 (1989).
Rocklage et al., "Structural and Thermodynamic Characterization of Manganese(II) N,N'Dipyridoxyl-ethylendiamine-N,N'-diacetate. A Novel Manganese(II) Chelate", Inorg. Chem., 27, pp. 3530-3534 (1988).
Sun et al., "Synthesis of Multidentate Ligands Containing Hydroxypyridyl Donor Groups," Tetrahedron, 47, pp. 357-364 (1991).
Taliaferro et al., "New Multidentate Ligands. XXIV. Disodium-N,N'bis(2-hydroxy-5-sulfobenzyl)ethylenediamine-diacetic acid, a new chelating ligand for trivalent metal ions", Chemical Abstracts, 101, p. 369, Abstract No. 44224j (1984).
Taliaferro et al., "New Multidentate Ligands. 22. N,N'-Dipyridoxylethylenediamine-N,N' diacetic Acid: A New Chelating Ligand for Trivalent Metal Ions", Inorg. Chem., 23, pp. 1188-1192 (1984).
Taliaferro et al., "New Multidentate Ligands. XXIV, Disodium-N,N'-bis(2-hydroxy-5-sulfobenzyl)-ethylenediaminediacetic Acid, a New Chelating Ligand for Trivalent Metal Ions", Inorganica Chimicia Acta, 85, pp. 9-15 (1984).
Theodorakis et al., "Localization of Technetium 99m-Ethylenediamine-N,N'-bis [(.alpha.-2-hydroxy-5-bromophenyl) acetic Acid and Technetium 99m-N-]2-Mercapto-1-oxopropyl) glycine in Hepatobiliary System", J. Pharm. Sci., 69, pp. 581-584 (1980).
Unger et al., "Magnetic Resonance Imaging Using Gadolinium-Labeled Monoclonal Antibody," Invest. Radiology, 20, pp. 693-700 (1985).
Weinmann et al., "Characteristics of Gadolinium-DTPA Complex: A Potential NMR Contrast Agent", AJR, 142, pp. 619-624 (1984).
Yeh et al., "A New Route to `Bifunctional` Chelating Agents: Conversion of Amino Acids to Analogs of Ethylenedinitrilo-tetraacetic Acid", Anal. Biochem., 100, pp. 152-159 (1979).
Martell et al., "Critical Stability Constants vol. 1, Amino Acids," pp. 124-125, 135, Plenum Press, New York (1974).
Lauffer Randall B.
Scott Daniel M.
Haley, Jr. James F.
Hendler Pablo D.
Hollinden Gary E.
Metasyn, Inc.
LandOfFree
1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-422108